MX2020009444A - Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion. - Google Patents
Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.Info
- Publication number
- MX2020009444A MX2020009444A MX2020009444A MX2020009444A MX2020009444A MX 2020009444 A MX2020009444 A MX 2020009444A MX 2020009444 A MX2020009444 A MX 2020009444A MX 2020009444 A MX2020009444 A MX 2020009444A MX 2020009444 A MX2020009444 A MX 2020009444A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- isotretinoin
- low dose
- dose oral
- Prior art date
Links
- 239000008203 oral pharmaceutical composition Substances 0.000 title abstract 3
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical group OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 title abstract 2
- 229960005280 isotretinoin Drugs 0.000 title abstract 2
- 230000009246 food effect Effects 0.000 abstract 1
- 235000021471 food effect Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona una composición farmacéutica oral de baja dosis de isotretinoína que tiene efecto con alimento reducido. La presente invención además se relaciona a un proceso para preparar la composición farmacéutica oral de la presente invención.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2827DE2014 | 2014-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020009444A true MX2020009444A (es) | 2020-10-08 |
Family
ID=55629490
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017004312A MX2017004312A (es) | 2014-10-01 | 2015-05-29 | Composicion farmaceutica oral de baja dosis de isotretinoina. |
MX2020009444A MX2020009444A (es) | 2014-10-01 | 2017-03-31 | Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017004312A MX2017004312A (es) | 2014-10-01 | 2015-05-29 | Composicion farmaceutica oral de baja dosis de isotretinoina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160128962A1 (es) |
EP (1) | EP3200877A4 (es) |
JP (1) | JP6707532B2 (es) |
AU (1) | AU2015326489A1 (es) |
BR (1) | BR112017006779A2 (es) |
CA (2) | CA2963206C (es) |
MA (1) | MA40781A (es) |
MX (2) | MX2017004312A (es) |
RU (1) | RU2707753C2 (es) |
WO (1) | WO2016051288A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3174601A4 (en) * | 2014-07-31 | 2018-01-10 | Sun Pharmaceutical Industries Ltd | Oral pharmaceutical composition of isotretinoin |
WO2017203365A1 (en) | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratiories Ltd. | Pharmaceutical compositions for treating acne |
WO2018073751A1 (en) * | 2016-10-17 | 2018-04-26 | Sun Pharmaceutical Industries Limited | Method of treating acne |
US10716774B1 (en) | 2018-01-05 | 2020-07-21 | Yale Pharmaceuticals LLC | Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability |
TW202320728A (zh) * | 2021-11-04 | 2023-06-01 | 日商興和股份有限公司 | 醫藥品 |
TW202320776A (zh) * | 2021-11-04 | 2023-06-01 | 日商興和股份有限公司 | 膠囊劑 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20001227A1 (es) * | 1998-10-30 | 2000-11-06 | Hoffmann La Roche | Procesos para producir una composicion de isotretinoina |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
FR2807662A1 (fr) * | 2000-04-12 | 2001-10-19 | Cll Pharma | Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications |
DE60104206T2 (de) * | 2000-09-22 | 2005-09-22 | Galephar M/F | Halbfeste arzneizubereitung enthaltend isotretinoin |
BR0117191A (pt) * | 2001-12-06 | 2005-05-10 | Ranbaxy Lab Ltd | Composições nanoparticuladas de isotretinoina |
US10028972B2 (en) * | 2010-10-21 | 2018-07-24 | Cadila Healthcare Limited | Pharmaceutical compositions of anti-acne agents |
US20120321579A1 (en) * | 2011-01-24 | 2012-12-20 | Anterios, Inc. | Surfactant compositions |
US9078925B2 (en) * | 2012-06-18 | 2015-07-14 | Galephar Pharmaceutical Research, Inc. | Pharmaceutical semi-solid composition of isotretinoin |
CA2987177A1 (en) * | 2015-05-25 | 2016-12-01 | Sun Pharmaceutical Industries Limited | Once-daily oral pharmaceutical composition of isotretinoin |
-
2015
- 2015-05-28 MA MA040781A patent/MA40781A/fr unknown
- 2015-05-29 WO PCT/IB2015/054080 patent/WO2016051288A1/en active Application Filing
- 2015-05-29 EP EP15845766.3A patent/EP3200877A4/en not_active Withdrawn
- 2015-05-29 RU RU2017114924A patent/RU2707753C2/ru active
- 2015-05-29 AU AU2015326489A patent/AU2015326489A1/en not_active Abandoned
- 2015-05-29 CA CA2963206A patent/CA2963206C/en active Active
- 2015-05-29 BR BR112017006779-0A patent/BR112017006779A2/pt not_active Application Discontinuation
- 2015-05-29 MX MX2017004312A patent/MX2017004312A/es active IP Right Grant
- 2015-05-29 JP JP2017517643A patent/JP6707532B2/ja active Active
- 2015-05-29 CA CA3207801A patent/CA3207801A1/en active Pending
- 2015-12-03 US US14/958,467 patent/US20160128962A1/en not_active Abandoned
-
2017
- 2017-03-31 MX MX2020009444A patent/MX2020009444A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP6707532B2 (ja) | 2020-06-10 |
RU2707753C2 (ru) | 2019-11-29 |
MX2017004312A (es) | 2017-07-07 |
CA2963206A1 (en) | 2016-04-07 |
BR112017006779A2 (pt) | 2018-01-09 |
MA40781A (fr) | 2017-08-08 |
EP3200877A1 (en) | 2017-08-09 |
EP3200877A4 (en) | 2018-05-23 |
CA2963206C (en) | 2023-09-26 |
RU2017114924A (ru) | 2018-11-02 |
JP2017530149A (ja) | 2017-10-12 |
CA3207801A1 (en) | 2016-04-07 |
US20160128962A1 (en) | 2016-05-12 |
AU2015326489A1 (en) | 2017-04-27 |
RU2017114924A3 (es) | 2019-01-16 |
WO2016051288A1 (en) | 2016-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20207074B (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
GEP20207075B (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
GEP20207076B (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
TW201613859A (en) | Analogs of PRIDOPIDINE, their preparation and use | |
IN2014CH00247A (es) | ||
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
MX2020009444A (es) | Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion. | |
MX2016015464A (es) | Composicion farmaceutica oral de isotretinoina. | |
IN2013MU00646A (es) | ||
PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
MX2017001487A (es) | Sofosbuvir en forma cristalina y proceso para su preparacion. | |
ZA201604976B (en) | Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them | |
MX2017015137A (es) | Composicion farmaceutica oral de dosis diaria de isotretinoin. | |
IN2014CH00840A (es) | ||
MX2017011389A (es) | Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos. | |
MX2016015465A (es) | Composicion farmaceutica oral de isotretinoina. | |
PL3236764T3 (pl) | Sposób wytwarzania kompozycji przyprawowych | |
MA40447A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
EP3196186A4 (en) | Method for producing vapor composition containing lactic acid | |
PL3223799T3 (pl) | Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer | |
MX2016015623A (es) | Proceso para la preparacion de derivados dihidroisoxazol. | |
MX2016016398A (es) | Preparacion de piperidin-4-carbotioamida. | |
MA40444A (fr) | Procédé de préparation de formulations de poudre sèche | |
MX2017004770A (es) | Formas solidas del clorhidrato de nilotinib. | |
IN2014CH01391A (es) |